By Sean Moloughney, Editor10.08.21
Thanks to a vast and growing dossier of clinical data supporting numerous health benefits, the overall omega-3 market is in stable territory. Like other segments, the COVID-19 pandemic has created opportunities and presented challenges for omega-3 manufacturers, brand holders, suppliers, and stakeholders up and down the value chain. For the future, omega-3 sources, sustainability, and product differentiation that can grow the category will be hot topics.
The omega-3 supplement market was “fairly topsy-turvy in 2020,” according to Ellen Schutt, executive director of the Global Organization for EPA and DHA Omega-3s (GOED), due in large part to the pandemic.
“In the early months, consumers were stockpiling supplements in general, including omega-3s,” she noted. “We saw some spikes here and there throughout the year as scientific news related to the role of inflammation in COVID morbidity and mortality sparked occasional additional jumps in omega-3 supplement sales, but sales stabilized by the fourth quarter of
The omega-3 supplement market was “fairly topsy-turvy in 2020,” according to Ellen Schutt, executive director of the Global Organization for EPA and DHA Omega-3s (GOED), due in large part to the pandemic.
“In the early months, consumers were stockpiling supplements in general, including omega-3s,” she noted. “We saw some spikes here and there throughout the year as scientific news related to the role of inflammation in COVID morbidity and mortality sparked occasional additional jumps in omega-3 supplement sales, but sales stabilized by the fourth quarter of
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
